Hepion Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 07/14/2023 | 3.31 M | $2.57 M | 0.00% | 4.34% |
| BLACKROCK INC. | 05/12/2023 | 1.60 M | $1.24 M | 0.33% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 656,453 | $509,736 | 0.00% | 0.86% |
| STATE STREET CORP | 05/15/2023 | 313,500 | $243,433 | 0.00% | 0.41% |
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 284,300 | $221,000 | 15.76% | 0.37% |
| ENVESTNET ASSET MANAGEMENT INC | 05/11/2023 | 156,909 | $121,840 | -22.70% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 154,754 | $120,166 | 61.32% | 0.20% |
| NORTHERN TRUST CORP | 05/15/2023 | 132,059 | $102,544 | 0.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 05/09/2023 | 88,715 | $68,887 | 0.00% | 0.12% |
| MORGAN STANLEY | 05/15/2023 | 88,216 | $68,500 | 9.72% | 0.12% |
| MCADAM, LLC | 04/24/2023 | 62,169 | $48,274 | 0.00% | 0.08% |
| PNC FINANCIAL SERVICES GROUP, INC. | 05/15/2023 | 57,534 | $44,646 | -0.10% | 0.08% |
| VIRTU FINANCIAL LLC | 05/01/2023 | 53,501 | $42,000 | 152.78% | 0.07% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2023 | 47,524 | $36,898 | 41.02% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 37,000 | $28,860 | -35.20% | 0.05% |
| CITADEL ADVISORS LLC | 05/15/2023 | 34,800 | $27,022 | 14.10% | 0.05% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/12/2023 | 31,535 | $24,487 | 0.00% | 0.04% |
| TWO SIGMA ADVISERS, LP | 05/15/2023 | 25,900 | $20,111 | 0.00% | 0.03% |
| CETERA INVESTMENT ADVISERS | 05/15/2023 | 19,746 | $15,333 | -33.59% | 0.03% |
| UBS GROUP AG | 05/12/2023 | 14,070 | $10,918 | 100.00% | 0.02% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 05/15/2023 | 13,306 | $10,332 | 100.00% | 0.02% |
| GROUP ONE TRADING, L.P. | 05/12/2023 | 13,128 | $10,194 | -46.06% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 10,564 | $8,000 | -67.28% | 0.01% |
| AMPLIUS WEALTH ADVISORS, LLC | 04/25/2023 | 10,000 | $7,765 | 0.00% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/15/2024 | 3,500 | $2,720 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2023 | 1,648 | $1,280 | -61.54% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 528 | $410 | 1.73% | 0.00% |
| BARCLAYS PLC | 05/04/2023 | 309 | $0 | 0.00% | 0.00% |
| SIGNATUREFD, LLC | 04/28/2023 | 2 | $2 | 0.00% | 0.00% |
| HARBOR INVESTMENT ADVISORY, LLC | 04/21/2023 | 1 | $1 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 04/18/2023 | 1 | $1 | 100.00% | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 04/27/2023 | 1 | $0 | -99.90% | 0.00% |
| CAPITAL ADVISORS, LTD. LLC | 05/03/2023 | 1 | $0 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| PVG ASSET MANAGEMENT CORP | 07/24/2023 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 04/14/2023 | 0 | $0 | -100.00% | 0.00% |
| IFP ADVISORS, INC | 04/18/2023 | 0 | $0 | -100.00% | 0.00% |
Hepion Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Hepion Pharmaceuticals, Inc.. The most heavily invested institutionals were:
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA): 10,000
LADENBURG THALMANN FINANCIAL SERVICES INC.: 47
Advisor Group, Inc.: 1
9.38% of Hepion Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10,048 shares in the last 24 months. This purchase volume represents approximately $5,024 in transactions.